| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f591ef1a56724a2abf77d0e1ae55d0fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_031a6c59fb55f2487dcd1e41ec5c94f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ab4fdd51d2ded6090117d6902866f4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6893563d80a3c42988cd56387ea5e1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa517a000c7e3b025569282c87bffa89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a3759ab8252a2a9a42e27eb09d582f5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-706 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2010-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5ccf7040a3825b20a4f677931ac5473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70b914b887a61fb5ffefea29e43d44dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d0026416734b5eee6fd81ed202371fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7102ced1b5e236a75fb696ca7719eaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e32a145aead8dace1661d5b9dbb0b811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7aba225b54f3b09f191c220b578a1a7 |
| publicationDate |
2010-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010149767-A1 |
| titleOfInvention |
Method for determining the risk of occurence of liver fibrosis in an individual |
| abstract |
The present invention relates to an in vitro method for determining that an individual with a chronic hepatitis C virus infection is at risk of developing liver fibrosis, which comprises: - determining whether the individual harbours at least one variant allele of the interferon-γ receptor 2 ( IFNGR2 ) gene; - deducing that if the individual harbours at least one variant allele of the IFNGR2 gene then the individual is at risk of developing liver fibrosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013079711-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019076830-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3373012-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3470843-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10198552-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018162502-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013150002-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2600266-A1 |
| priorityDate |
2009-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |